Have you got room for a blue chip or two in your portfolio? If you have, then take a look at the blockbuster blue chip shares listed below.
Here’s why they are highly rated:
CSL Limited (ASX: CSL)
The first blue chip ASX 200 share for investors to look at is CSL. It is one of the world’s leading biotechnology companies, comprising the CSL Behring and Seqirus businesses. It is also looking to add to its portfolio with the acquisition of Vifor Pharma.
This will build on its leadership position in plasma therapies and vaccines by adding treatments for iron deficiency, dialysis, and nephrology.
CSL’s shares have been underperforming over the last couple of years. This has been driven by plasma collection headwinds. However, these headwinds are beginning to ease and collections are becoming easier again.
In light of this, the team at Citi believe now could be a good time to invest. It recently reaffirmed its buy rating and $335 price target. This compares favourably to the latest CSL share price of $273.30.
REA Group Limited (ASX: REA)
Another ASX 200 blue chip share for investors to look at is REA Group. It is the dominant player in real estate listings in the Australian market.
REA has been tipped to continue its growth in the coming years. This is due to the strength of the housing market, new revenue streams, cost cutting, price increases, its international operations, and acquisitions. The latter has seen REA grow its presence in mortgage broking through the acquisition of Mortgage Choice.
Goldman Sachs is very positive on the company and has a buy rating and $170.00 price target on its shares. This compares to the latest REA share price of $129.42.